Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02034032 · ClinicalTrials.gov registry record · NA

Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA

A NA study of Knee Osteoarthritis, sponsored by Regenexx.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT02034032 is a NA study of Knee Osteoarthritis that has completed, run by Regenexx. The registered enrollment target is 48 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02034032, a NA study of Knee Osteoarthritis, has completed, sponsored by Regenexx.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to evaluate the efficacy of Regenexx SD compared to Exercise Therapy at three months. Historical comparison will be made to Total Knee Arthroplasty for treatment of knee osteoarthritis at 1 and 2 years.

Conditions Studied

Knee Osteoarthritis

Interventions

  • BEHAVIORAL Exercise Therapy
  • PROCEDURE Regenexx SD

Study Locations (1)

Illinois

  • Regenerative Pain Center; Weil Foot, Ankle and Orthopedic Institute - Des Plaines

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2014-01
Est. Completion 2018-12
Phase NA

Sponsor

Regenexx

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02034032

The ClinicalTrials.gov registry entry for NCT02034032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (84% lower). The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Exercise Therapy is the first listed.

NCT02034032 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02034032 about?

NCT02034032 is a clinical study titled "Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA". The primary objective of this study is to evaluate the efficacy of Regenexx SD compared to Exercise Therapy at three months. Historical comparison will be made to Total Knee Arthroplasty for treatment of knee osteoarthritis at 1 and 2 years.

What is the current status of trial NCT02034032?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2014-01. Estimated completion is 2018-12.

What conditions does trial NCT02034032 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT02034032?

The interventions under investigation include: Exercise Therapy (BEHAVIORAL), Regenexx SD (PROCEDURE).

Who is sponsoring clinical trial NCT02034032?

This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02034032 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Knee Osteoarthritis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.